Espee Pharma (UK) Limited

Active08868139 Private limited company

Incorporated: 30 January 2014 (12 years)
Industry: Dispensing chemist in specialised stores (47730)
Directors: Anar Swapnil Shah
Kamlesh Kanubhai Patel
Nishant Kamlesh Patel
all 4 directors
Owned by: Ric Chemicals Limited
Accounts type: Total exemption full
Region: Greater London
Address: Unit 1 Conqueror Court
Spilsby Road Harold Hill
Romford
RM3 8SB

Filing status

Accounts due: 31 March 2027
Last accounts: 30 June 2025
Conf. stmt due: 14 April 2027
Last conf. stmt: 31 March 2026

Officers 5 active

Officer details are public data from the Companies House register.

Shah, Anar Swapnil

Director · Appointed 28 June 2024

Indian

Born January 1988 (38)

Patel, Kamlesh Kanubhai

Director · Appointed 1 November 2022

Also at Liqmeds Lifecare Limited, Liqmeds Worldwide Limited, Medsolutions (Europe) Limited · more companies

British

Born November 1958

Patel, Nishant Kamlesh

Secretary · Appointed 30 January 2014

Patel, Nishant Kamlesh

Director · Appointed 30 January 2014

British

Born May 1986 (40)

Shah, Shashin Hemendra

Director · Appointed 30 January 2014

American

Born September 1984 (42)

Officer history (2 former)

28 June 2024

Appointed Shah, Anar Swapnil as Director

28 June 2024

Resigned Shah, Swapnil as Director

20 June 2023

Resigned Patel, Ravi as Director

1 November 2022

Appointed Patel, Kamlesh Kanubhai as Director

30 January 2014

Appointed Patel, Nishant Kamlesh as Secretary

30 January 2014

Appointed Patel, Nishant Kamlesh as Director

30 January 2014

Appointed Shah, Shashin Hemendra as Director

30 January 2014

Appointed Patel, Ravi as Director

30 January 2014

Appointed Shah, Swapnil as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Ric Chemicals Limited

Corporate entity · Notified 6 April 2016

Owns 25–50% of shares

Holds 25–50% of voting rights

Limited Company

Reg. no. 03091306

Former controllers (1)

10 June 2026

Ceased Espee Biopharma & Finechem LLC — Owns 25–50% of shares

Group structure 3 companies

Ownership group derived from the Companies House PSC register

Ric Chemicals Limited

Bravo Pharma (UK) Ltd Owns 25–50% of shares

Espee Pharma (UK) Limited This company Owns 25–50% of shares

Financials

Balance sheet as at 30 June 2025 · total exemption full accounts

Net Assets: £351,066
Cash: £352,158
Employees: 3

Debt Ratio: 44%

Trend

Net Assets

Balance sheet detail

	2025	2024	2023	2022	2021	2020	2019
Fixed Assets	£24,395	£538	£538	£717	£956	£1,275	£1,700
Current Assets	£604,248	£995,499	£464,571	£580,693	£512,151	£543,901	£440,349
Debtors	£152,701	£268,022	£122,851	£218,262
Cash	£352,158	£583,743	£222,355	£298,331	£448,651	£87,753	£56,212
Creditors (< 1 year)					£114,095	£376,560	£309,773
Creditors (> 1 year)		£0	£78,880	£190,683	£209,951	£9,950
Net Current Assets	£326,671	£299,322	£328,666	£417,980	£398,056	£167,341	£130,576
Net Assets	£351,066	£299,860	£250,324	£228,014	£189,061	£158,666	£132,276
Shareholder Funds					£189,061	£158,666	£132,276

Turnover		£4,376,643	£2,072,542	£2,649,049	£3,098,403	£1,984,564	£2,310,064
Cost of Sales		£3,771,331	£1,804,016	£2,337,064	£2,860,944	£1,671,905	£2,014,970
Gross Profit		£605,312	£268,526	£311,985	£237,459	£312,659	£295,094
Admin Expenses		£520,225	£240,941	£263,001	£196,380	£260,099	£206,373
Operating Profit		£85,087			£39,281	£32,851	£76,986
Profit Before Tax		£62,294	£27,585	£48,984	£39,281	£32,741	£76,960
Tax		£12,758	£5,275	£10,031	£8,886	£6,352	£14,730
Profit for Period		£49,536	£22,310	£38,953	£30,395	£26,389	£62,230

Filings

Recent filings only. See the full history on Companies House

Date	Description	Made Up To
30 June 2026	Total exemption full accounts	30 June 2025
17 June 2026	Director's details changed
17 June 2026	Confirmation statement with no updates	31 March 2026
10 June 2026	Director's details changed
10 June 2026	Secretary's details changed